Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05420324 |
| Consolidated Lead Sponsor | Eucure (Beijing) Biopharma Co |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 20 participants (ACTUAL) |
| Registered Start Date | 2022-06-13 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Sun Yat-sen University Cancer Center | Guangzhou, China | Open Hospital Dossier -> |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan, China | Open Hospital Dossier -> |
| Hunan Cancer Hospital | Changsha, China | Open Hospital Dossier -> |
| Nanjing Drum Tower Hospital | Nanjing, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.